Hillenbrand Releases Investor Roadshow Materials and Updated Financial Guidance Related to Separation Of Hill-Rom and Batesvi...(.476 billion. Capital sales are expected...),Health

Date:3/13/2008

.476 billion. Capital sales are expected to be in the range of $0.991 - 1.022 billion while Hill-Rom rental revenues are expected to be between $435 - 454 million. Hill-Rom projects GAAP earnings per fully diluted share of $1.11 - 1.30, with adjusted earnings per fully diluted share of $1.13 - 1.32. These amounts have been adjusted from previously provided guidance to reflect the impacts of Hill-Rom's new capital structure on interest expense and to eliminate other income associated with the transfer of certain investments to Batesville in conjunction with the separation. The effective tax rate has also been adjusted to give effect to the separation, along with the expiration of the research and development tax credit earlier this year. It is important to note that the above earnings guidance, both on a GAAP and as adjusted basis, exclude the effects of certain one-time costs associated with the separation, including the modification of equity compensation awards, costs associated with the repurchase of Hillenbrand debt contemplated in the transaction and other separation-related costs. These costs have been excluded due to the difficulty in predicting such amounts and the fact that many of these costs will be reflected as a component of discontinued operations in Hill-Rom's future reporting.

Batesville Holdings, Inc, to be the parent company of Batesville Casket, will change its name to Hillenbrand, Inc. in connection with the separation. For fiscal year 2008, Batesville continues to expect revenue of $668 - 686 million, with GAAP earnings per fully diluted share of $1.27 - 1.47, and adjusted fully diluted earnings per share of $1.64 - 1.79. Adjusted fully diluted earnings exclude the effects of the anticipated equity compensation modification and other separation-related costs estimated to be $16 - 18 million (pre-tax) and anti-trust litigation costs in 2008.

All current and potential investors are encouraged to review the Disclosure Regarding Forwar
'/>"/>

SOURCE Hillenbrand Industries, Inc. Copyright©2008 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8
Related medicine news :

1. Hillenbrand Industries Announces Fourth Quarter 2007 Dividend
2. Hillenbrand Industries Announces Second Quarter 2008 Dividend
3. Hillenbrand Announces Mailing of Proxy Regarding Changing of Company Name in Conjunction with Planned Separation
4. Hillenbrand Industries, Inc. Announces Any and All Cash Tender Offer for Its 4.50 percent Senior Notes Due 2009
5. Cleveland Clinic Press Releases Journal-Writing Book Write for Life: Healing Body, Mind, and Spirit Through Journal Writing by Sheppard B. Kominars, Ph.D.
6. Leading Child Abuse Center Releases Back to School Tips to Protect Children From Internet Predators
7. JHA Releases 2007 U.S. Group Disability Mid-Year Market Survey Results
8. Verdict One Releases Directory of Board Certified Attorneys for Consumers
9. Academy releases emergency preparedness tools to enable millions more people to shelter in place
10. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
11. MITEM Releases Blue Iris eLaborate 8.6